Literature DB >> 11067992

Angiotensin II increases neuronal delayed rectifier K(+) current: role of 12-lipoxygenase metabolites of arachidonic acid.

M Zhu1, R Natarajan, J L Nadler, J M Moore, C H Gelband, C Sumners.   

Abstract

Angiotensin II (Ang II) elicits an Ang II type 2 (AT(2)) receptor-mediated increase in voltage-dependent delayed rectifier K(+) current (I(KV)) in neurons cultured from newborn rat hypothalamus and brain stem. In previous studies, we have determined that this effect of Ang II is mediated via a Gi protein, activation of phospholipase A(2) (PLA(2)), and generation of arachidonic acid (AA). AA is rapidly metabolized within cells via lipoxygenases (LO), cyclooxygenase (COX) or p450 monooxygenase enzymes, and the metabolic products are known regulators of K(+) currents and channels. Thus in the present study, we have investigated whether the AT(2) receptor-mediated effects of Ang II on neuronal I(KV) require AA metabolism and if so, which metabolic pathways are involved. The data presented here indicate that the stimulatory actions of Ang II and AA on neuronal I(KV) are attenuated by selective blockade of 12-LO enzymes. However, the effects of Ang II are not altered by blockade of 5-LO or p450 monooxygenase enzymes. Furthermore, the actions of Ang II are mimicked by a 12-LO metabolite of AA, but 5-LO metabolites such as leukotriene B(4) and C(4) do not alter neuronal I(KV). These data indicate that the AT(2) receptor-mediated stimulation of neuronal I(KV) is partially mediated through 12-LO metabolites of AA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067992     DOI: 10.1152/jn.2000.84.5.2494

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  8 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Activation of delta-opioid receptors reduces excitatory input to putative gustatory cells within the nucleus of the solitary tract.

Authors:  Mingyan Zhu; Young K Cho; Cheng-Shu Li
Journal:  J Neurophysiol       Date:  2008-11-19       Impact factor: 2.714

3.  Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats.

Authors:  Claudia A McCarthy; Antony Vinh; Alyson A Miller; Anders Hallberg; Mathias Alterman; Jennifer K Callaway; Robert E Widdop
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 4.  AT2 receptor signaling and sympathetic regulation.

Authors:  Lie Gao; Irving H Zucker
Journal:  Curr Opin Pharmacol       Date:  2010-12-13       Impact factor: 5.547

5.  Pharmacological characterization of a non-inactivating outward current observed in mouse cerebellar Purkinje neurones.

Authors:  Trevor Bushell; Catherine Clarke; Alistair Mathie; Brian Robertson
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 6.  Neural Control of Non-vasomotor Organs in Hypertension.

Authors:  Chansol Hurr; Colin N Young
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

7.  Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure.

Authors:  Lie Gao; Wei-Zhong Wang; Wei Wang; Irving H Zucker
Journal:  Hypertension       Date:  2008-09-02       Impact factor: 10.190

8.  Compensatory Vasodilator Mechanisms in the Ophthalmic Artery of Endothelial Nitric Oxide Synthase Gene Knockout Mice.

Authors:  Caroline Manicam; Natalja Ginter; Huige Li; Ning Xia; Evgeny Goloborodko; Jenia Kouchek Zadeh; Aytan Musayeva; Norbert Pfeiffer; Adrian Gericke
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.